Market Closed -
OTC Markets
12:31:57 29/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.002
USD
|
0.00%
|
|
-77.01%
|
-78.02%
|
Fiscal Period: May |
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
18.61
|
32.21
|
36.33
|
9.99
|
Enterprise Value (EV)
1 |
17.02
|
30.85
|
36.4
|
11.14
|
P/E ratio
|
-7.57
x
|
-10.2
x
|
-7.9
x
|
-2.63
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7,75,55,627
x
|
24,15,77,948
x
|
-
|
3,40,51,910
x
|
EV / Revenue
|
7,09,34,858
x
|
23,13,47,856
x
|
-
|
3,79,69,265
x
|
EV / EBITDA
|
-8.52
x
|
-13.6
x
|
-11.3
x
|
-2.71
x
|
EV / FCF
|
-1,32,52,150
x
|
-1,74,40,536
x
|
-1,82,69,446
x
|
-81,80,367
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
8.21
x
|
9.13
x
|
16
x
|
-32.1
x
|
Nbr of stocks (in thousands)
|
25,307
|
32,758
|
35,938
|
38,909
|
Reference price
2 |
0.7355
|
0.9833
|
1.011
|
0.2567
|
Announcement Date
|
30/09/19
|
28/09/20
|
28/09/21
|
28/09/22
|
Fiscal Period: May |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
0.0267
|
0.24
|
0.1333
|
-
|
0.2934
|
EBITDA
1 |
-1.115
|
-1.629
|
-1.998
|
-2.269
|
-3.212
|
-4.114
|
EBIT
1 |
-1.116
|
-1.681
|
-2.079
|
-2.447
|
-3.594
|
-4.606
|
Operating Margin
|
-
|
-6,303.01%
|
-866.08%
|
-1,835.39%
|
-
|
-1,570.01%
|
Earnings before Tax (EBT)
1 |
-1.116
|
-2.408
|
-2.459
|
-2.607
|
-4.42
|
-3.689
|
Net income
1 |
-1.116
|
-2.408
|
-2.459
|
-2.607
|
-4.42
|
-3.689
|
Net margin
|
-
|
-9,031.44%
|
-1,024.41%
|
-1,955.42%
|
-
|
-1,257.55%
|
EPS
2 |
-0.2980
|
-0.1140
|
-0.0972
|
-0.0960
|
-0.1279
|
-0.0978
|
Free Cash Flow
|
-
|
-0.8683
|
-1.285
|
-1.769
|
-1.993
|
-1.362
|
FCF margin
|
-
|
-3,256.05%
|
-535.27%
|
-1,326.5%
|
-
|
-464.15%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/04/18
|
28/09/18
|
30/09/19
|
28/09/20
|
28/09/21
|
28/09/22
|
Fiscal Period: May |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
0.08
|
1.15
|
Net Cash position
1 |
0.96
|
4.22
|
1.59
|
1.36
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.0234
x
|
-0.2793
x
|
Free Cash Flow
|
-
|
-0.87
|
-1.28
|
-1.77
|
-1.99
|
-1.36
|
ROE (net income / shareholders' equity)
|
-
|
-90.2%
|
-74.8%
|
-90%
|
-152%
|
-377%
|
ROA (Net income/ Total Assets)
|
-
|
-35.7%
|
-35.4%
|
-37.8%
|
-37.8%
|
-62.5%
|
Assets
1 |
-
|
6.748
|
6.948
|
6.906
|
11.68
|
5.904
|
Book Value Per Share
2 |
0.2200
|
0.1700
|
0.0900
|
0.1100
|
0.0600
|
-0.0100
|
Cash Flow per Share
2 |
0.2000
|
0.1700
|
0.0200
|
0.0600
|
0.0400
|
0.0200
|
Capex
1 |
0.1
|
0.11
|
0.25
|
0.79
|
0.27
|
0.03
|
Capex / Sales
|
-
|
398.18%
|
104.15%
|
593.35%
|
-
|
10.26%
|
Announcement Date
|
19/04/18
|
28/09/18
|
30/09/19
|
28/09/20
|
28/09/21
|
28/09/22
|
|
1st Jan change
|
Capi.
|
---|
| -78.02% | 77.82K | | +26.93% | 5.55B | | -33.55% | 3.52B | | -3.74% | 3.03B | | -26.09% | 2.59B | | -10.93% | 2.28B | | +41.50% | 1.88B | | +41.84% | 1.46B | | -12.94% | 1.43B | | +47.62% | 1.42B |
Alternative Medicine
|